Stock listing
gettex:UP0 Ultragenyx Pharmaceutical Inc. Aktie
German listing (gettex) of Ultragenyx Pharmaceutical Inc. · home listing NASDAQ:RARE
Follow Ultragenyx Pharmaceutical Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:RARE
$17.20 USD +0.45 (+2.7%)
Close on Oct 28, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RARE
- Day range
- $16.47 – $17.35 USDOct 28, 2026
- Volume
- 2.32M sharesOct 28, 2026
- Market cap
- $1.70B USDAt the close on Oct 28, 2026 · price × 98.59M shares outstanding
- 52-week range
- $12.73 – $39.89 USDLowest and highest trades, Oct 29, 2025 – Oct 28, 2026
- Traded on an average day
- $71.92M USDMedian day 3.14M shares · last 3 months, Jul 28, 2026 – Oct 28, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RARE · Home | $17.20 USD | +0.45 (+2.7%) | 2,319,744 | $16.73 | $17.35 | $16.47 | $16.75 | Close on Oct 28, 2026 |
| LSE:0LIF | $16.77 USD | +1.09 (+7.0%) | 5,542 | $16.00 | $16.95 | $15.87 | $15.68 | Close on Oct 27, 2026 |
| Frankfurt:UP0 | €14.24 EUR | +0.34 (+2.4%) | — | €14.24 | €14.24 | €14.24 | €13.90 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 28, 2026 – Oct 28, 2026 · NASDAQ:RARE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $17.20 | +0.45 | +2.7% | $16.73 | $17.35 | $16.47 | 2,319,744 | |
| $16.75 | +0.67 | +4.2% | $16.05 | $16.96 | $15.88 | 4,943,979 | |
| $16.08 | +0.43 | +2.7% | $15.77 | $16.22 | $15.60 | 3,022,884 | |
| $15.65 | -0.30 | -1.9% | $15.92 | $15.94 | $15.49 | 1,789,100 | |
| $15.95 | +0.03 | +0.2% | $15.78 | $16.25 | $15.60 | 2,374,100 | |
| $15.92 | -0.10 | -0.6% | $16.02 | $16.31 | $15.79 | 2,825,000 | |
| $16.02 | +0.95 | +6.3% | $15.01 | $16.27 | $14.99 | 3,546,000 | |
| $15.07 | +0.53 | +3.6% | $14.67 | $15.08 | $14.54 | 2,984,400 | |
| $14.54 | -0.63 | -4.2% | $15.11 | $15.21 | $14.44 | 2,924,000 | |
| $15.17 | +0.27 | +1.8% | $14.87 | $15.37 | $14.79 | 3,332,000 | |
| $14.90 | -0.02 | -0.1% | $14.93 | $15.18 | $14.67 | 2,953,000 | |
| $14.92 | -0.38 | -2.5% | $15.27 | $15.39 | $14.69 | 5,305,200 | |
| $15.30 | -0.18 | -1.2% | $15.42 | $15.49 | $15.10 | 2,898,600 | |
| $15.48 | +0.19 | +1.2% | $15.30 | $15.73 | $15.23 | 2,927,600 | |
| $15.29 | +0.40 | +2.7% | $14.79 | $15.52 | $14.43 | 5,396,500 | |
| $14.89 | +0.43 | +3.0% | $14.37 | $15.25 | $14.35 | 4,162,500 | |
| $14.46 | -0.04 | -0.3% | $14.60 | $14.70 | $14.08 | 3,892,000 | |
| $14.50 | -0.72 | -4.7% | $15.25 | $15.31 | $14.21 | 4,656,500 | |
| $15.22 | +0.47 | +3.2% | $14.90 | $15.28 | $14.67 | 3,880,500 | |
| $14.75 | -0.28 | -1.9% | $15.03 | $15.25 | $14.62 | 4,116,000 | |
| $15.03 | -0.29 | -1.9% | $15.48 | $15.53 | $14.86 | 4,421,200 | |
| $15.32 | +0.91 | +6.3% | $14.46 | $15.50 | $14.11 | 5,884,600 | |
| $14.41 | -0.09 | -0.6% | $14.33 | $14.47 | $14.11 | 4,939,900 | |
| $14.50 | -0.27 | -1.8% | $14.87 | $14.94 | $14.15 | 4,303,700 | |
| $14.77 | -0.11 | -0.7% | $14.73 | $14.87 | $14.55 | 3,488,700 | |
| $14.88 | -0.735 | -4.7% | $15.40 | $15.50 | $14.54 | 5,704,900 | |
| $15.62 | +0.965 | +6.6% | $14.78 | $16.12 | $14.48 | 8,134,200 | |
| $14.65 | +0.14 | +1.0% | $14.58 | $15.01 | $14.28 | 5,269,500 | |
| $14.51 | +0.01 | +0.1% | $14.79 | $15.07 | $14.07 | 13,328,100 | |
| $14.50 | +1.62 | +12.6% | $13.22 | $14.58 | $13.20 | 12,427,800 | |
| $12.88 | -0.19 | -1.5% | $13.07 | $13.22 | $12.73 | 5,031,200 | |
| $13.07 | -0.54 | -4.0% | $13.56 | $13.59 | $12.88 | 5,655,000 | |
| $13.61 | -0.69 | -4.8% | $14.44 | $14.44 | $13.60 | 5,929,200 | |
| $14.30 | -0.10 | -0.7% | $14.43 | $14.70 | $14.13 | 3,252,100 | |
| $14.40 | +0.09 | +0.6% | $14.25 | $14.44 | $13.95 | 3,659,800 | |
| $14.31 | -0.57 | -3.8% | $14.77 | $15.20 | $14.27 | 4,573,600 | |
| $14.88 | -0.42 | -2.7% | $15.10 | $15.25 | $14.63 | 5,926,500 | |
| $15.30 | +0.45 | +3.0% | $15.48 | $16.08 | $15.23 | 11,494,500 | |
| $14.85 | -11.68 | -44.0% | $14.00 | $15.00 | $13.81 | 27,159,700 | |
| $26.53 | +0.72 | +2.8% | $25.96 | $26.80 | $25.57 | 7,170,800 | |
| $25.81 | +0.60 | +2.4% | $25.22 | $25.85 | $25.11 | 1,871,300 | |
| $25.21 | -0.40 | -1.6% | $25.45 | $25.90 | $24.73 | 1,934,100 | |
| $25.61 | -0.65 | -2.5% | $26.54 | $26.73 | $25.37 | 1,612,600 | |
| $26.26 | -0.18 | -0.7% | $26.38 | $26.56 | $25.83 | 1,142,600 | |
| $26.44 | -0.02 | -0.1% | $26.55 | $26.67 | $25.61 | 1,666,100 | |
| $26.46 | +0.74 | +2.9% | $26.25 | $26.92 | $26.00 | 3,807,810 | |
| $25.72 | -0.11 | -0.4% | $25.75 | $26.09 | $25.30 | 1,536,973 | |
| $25.83 | +0.51 | +2.0% | $25.76 | $26.75 | $25.69 | 2,392,300 | |
| $25.32 | -0.92 | -3.5% | $28.39 | $28.50 | $25.04 | 3,841,100 | |
| $26.24 | +0.75 | +2.9% | $26.28 | $26.68 | $26.00 | 2,846,600 | |
| $25.49 | -0.64 | -2.4% | $25.68 | $26.11 | $24.97 | 1,793,100 | |
| $26.13 | -0.36 | -1.4% | $26.26 | $26.51 | $25.81 | 1,315,700 | |
| $26.49 | +0.11 | +0.4% | $26.30 | $26.58 | $25.75 | 1,222,200 | |
| $26.38 | -0.48 | -1.8% | $27.07 | $27.17 | $26.33 | 946,100 | |
| $26.86 | -0.10 | -0.4% | $26.79 | $27.16 | $26.11 | 1,545,100 | |
| $26.96 | +0.16 | +0.6% | $27.16 | $27.59 | $26.42 | 2,138,800 | |
| $26.80 | +0.89 | +3.4% | $25.91 | $27.11 | $25.51 | 2,364,700 | |
| $25.91 | +0.09 | +0.3% | $26.34 | $26.71 | $25.30 | 3,829,200 | |
| $25.82 | +0.89 | +3.6% | $24.99 | $26.10 | $24.81 | 1,960,500 | |
| $24.93 | -0.88 | -3.4% | $28.48 | $28.48 | $24.61 | 2,642,400 | |
| $25.81 | +0.79 | +3.2% | $25.19 | $26.13 | $25.01 | 2,103,600 | |
| $25.02 | +0.11 | +0.4% | $24.92 | $25.40 | $24.01 | 2,085,700 | |
| $24.91 | -1.13 | -4.3% | $25.95 | $26.08 | $24.60 | 1,537,400 | |
| $26.04 | +1.04 | +4.2% | $25.04 | $26.10 | $24.55 | 2,675,800 | |
| $25.00 | -0.98 | -3.8% | $25.77 | $26.15 | $24.87 | 2,330,700 | |
| $25.98 | -0.91 | -3.4% | $26.57 | $27.29 | $25.22 | 1,844,400 |
- Ticker
- gettex:UP0
- Asset type
- Stock
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Oct 27, 2026
Ultragenyx to Host Conference Call for Third Quarter 2026 Financial Results and Corporate Update
Latest earnings call · Aug 4, 2026
Ultragenyx Pharmaceutical (NASDAQ:RARE) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Apr 30, 2026
Shareholder Meeting (April 2026)
Shareholder meeting · 7 slides
Calls
Upcoming
Ultragenyx Pharmaceutical (NASDAQ:RARE) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 5:00 PM ET
Register
Replays
Ultragenyx Pharmaceutical (NASDAQ:RARE) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 5:00 PM ET
Watch TranscriptUltragenyx Pharmaceutical (NASDAQ:RARE) Q1 2026 Earnings Call
Tue, May 05, 2026 · 5:00 PM ET
Watch TranscriptUltragenyx Pharmaceutical (NASDAQ:RARE) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 5:00 PM ET
Watch Transcript
Latest news
Ultragenyx to Host Conference Call for Third Quarter 2026 Financial Results and Corporate Update
Oct 27, 2026
Closed $17.20 (+2.7%) on Oct 28, 2026
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 Million
Oct 14, 2026
Closed $14.90 (-0.1%) on Oct 14, 2026
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
Oct 7, 2026
Closed $14.89 (+3.0%) on Oct 7, 2026
Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)
Oct 2, 2026
Closed $15.22 (+3.2%) on Oct 2, 2026
Ultragenyx Announces Approval of FAYUVI Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A
Sep 18, 2026
Closed $14.51 (+0.1%) on Sep 18, 2026
Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)
Sep 17, 2026
Closed $14.50 (+12.6%) on Sep 17, 2026
Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome
Sep 2, 2026
Closed $14.85 (-44.0%) on Sep 3, 2026
Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of GENGLYCOS™ (also known as DTX401) AAV Gene Therapy in GSDIa in The Journal of Inherited Metabolic Disease
Sep 1, 2026
Closed $26.53 (+2.8%) on Sep 2, 2026
Ultragenyx Announces U.S. FDA Approval of GENGLYCOS Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)
Aug 20, 2026
Closed $25.32 (-3.5%) on Aug 20, 2026
Ultragenyx Reports Second Quarter 2026 Financial Results and Corporate Update
Aug 4, 2026
Closed $24.93 (-3.4%) on Aug 5, 2026
Decks
Shareholder Meeting (April 2026)
Shareholder meeting · 7 slides · Apr 30, 2026
Q4 2025 Earnings Presentation
Earnings · 46 slides · Feb 12, 2026
Q2 2025 Earnings Presentation
Earnings · 42 slides · Aug 5, 2025
Technical Presentation (October 2023)
Technical · 22 slides · Oct 16, 2023
Ultragenyx Pharmaceutical Inc. on 6ix
- News releases
- 37 in the last 12 months · 220 in all · newest Oct 27, 2026 · oldest 2019
- Calls
- 22 calls with a replay · 22 with a transcript · latest Aug 4, 2026
- Decks
- 9 decks · latest Apr 30, 2026
Where Ultragenyx Pharmaceutical Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RARE · Home listing | NASDAQ | United States | USD |
| LSE:0LIF | LSE | United Kingdom | USD |
| gettex:UP0 · This page | gettex | Germany | EUR |
| BMV:RARE | BMV | Mexico | MXN |
| LS Exchange:A1XCY0 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1XCY0 | Lang & Schwarz | Germany | EUR |
| B3:R2AR34 | B3 | Brazil | BRL |
| BIVA:RARE | BIVA | Mexico | MXN |
| Frankfurt:UP0 | Frankfurt | Germany | EUR |
| Tradegate:UP0 | Tradegate | Germany | EUR |
| BOATS:RARE | BOATS | United States | USD |
| BX Swiss:UP0 | BX Swiss | Switzerland | CHF |
| Dusseldorf:UP0 | Dusseldorf | Germany | EUR |
| Hamburg:UP0 | Hamburg | Germany | EUR |
| Stuttgart:UP0 | Stuttgart | Germany | EUR |
| Hanover:UP0 | Hanover | Germany | EUR |
| Xetra:UP0 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Ultragenyx Pharmaceutical Inc.